Vanguard Group’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.29M Buy
192,328
+7,143
+4% +$42.4K ﹤0.01% 3708
2025
Q3
$813K Sell
185,185
-204
-0.1% -$968 ﹤0.01% 3842
2025
Q2
$823K Sell
185,389
-28,486
-13% -$119K ﹤0.01% 3792
2025
Q1
$1.21M Sell
213,875
-1,911
-0.9% -$24.5K ﹤0.01% 3656
2024
Q4
$4.55M Buy
215,786
+381
+0.2% +$8.75K ﹤0.01% 3311
2024
Q3
$5.79M Buy
215,405
+3,613
+2% +$106K ﹤0.01% 3215
2024
Q2
$6.04M Sell
211,792
-3,423
-2% -$120K ﹤0.01% 3174
2024
Q1
$9.13M Buy
215,215
+4,958
+2% +$223K ﹤0.01% 3012
2023
Q4
$11.2M Buy
210,257
+3,817
+2% +$172K ﹤0.01% 2878
2023
Q3
$8.88M Buy
206,440
+10,238
+5% +$472K ﹤0.01% 2945
2023
Q2
$10.8M Buy
196,202
+21,802
+13% +$1.2M ﹤0.01% 2903
2023
Q1
$7.32M Buy
174,400
+48,620
+39% +$1.44M ﹤0.01% 3112
2022
Q4
$3.48M Sell
125,780
-28,048
-18% -$691K ﹤0.01% 3460
2022
Q3
$3.94M Hold
153,828
﹤0.01% 3442
2022
Q2
$5.54M Sell
153,828
-38,624
-20% -$1.74M ﹤0.01% 3330
2022
Q1
$12M Buy
192,452
+21,883
+13% +$1.29M ﹤0.01% 3054
2021
Q4
$12M Sell
170,569
-9,602
-5% -$683K ﹤0.01% 3119
2021
Q3
$12.6M Sell
180,171
-12,416
-6% -$988K ﹤0.01% 3117
2021
Q2
$16M Buy
192,587
+40,254
+26% +$2.85M ﹤0.01% 2945
2021
Q1
$8.32M Sell
152,333
-31,039
-17% -$1.51M ﹤0.01% 3250
2020
Q4
$7.87M Sell
183,372
-19,238
-9% -$718K ﹤0.01% 3122
2020
Q3
$6.1M Sell
202,610
-12,117
-6% -$408K ﹤0.01% 3045
2020
Q2
$6.66M Buy
214,727
+14,437
+7% +$389K ﹤0.01% 2960
2020
Q1
$4.43M Buy
200,290
+54,170
+37% +$1.47M ﹤0.01% 3019
2019
Q4
$4.46M Buy
146,120
+14,460
+11% +$416K ﹤0.01% 3207
2019
Q3
$4.05M Sell
131,660
-47,524
-27% -$1.18M ﹤0.01% 3214
2019
Q2
$3.58M Sell
179,184
-4,481
-2% -$131K ﹤0.01% 3281
2019
Q1
$7.92M Sell
183,665
-515
-0.3% -$18.7K ﹤0.01% 2948
2018
Q4
$5.86M Buy
184,180
+2,940
+2% +$116K ﹤0.01% 3017
2018
Q3
$9.52M Buy
181,240
+25,449
+16% +$1.43M ﹤0.01% 2942
2018
Q2
$8.33M Buy
155,791
+19,450
+14% +$996K ﹤0.01% 2995
2018
Q1
$6.82M Sell
136,341
-17,912
-12% -$803K ﹤0.01% 3013
2017
Q4
$5.09M Sell
154,253
-3,054
-2% -$103K ﹤0.01% 3131
2017
Q3
$5.9M Buy
157,307
+3,305
+2% +$97.8K ﹤0.01% 3054
2017
Q2
$3.93M Buy
154,002
+2,558
+2% +$63.3K ﹤0.01% 3177
2017
Q1
$3.94M Buy
151,444
+2,244
+2% +$64.6K ﹤0.01% 3154
2016
Q4
$4.55M Buy
149,200
+388
+0.3% +$9.87K ﹤0.01% 3096
2016
Q3
$4.05M Buy
148,812
+5,921
+4% +$164K ﹤0.01% 3109
2016
Q2
$4.09M Sell
142,891
-5,654
-4% -$180K ﹤0.01% 3078
2016
Q1
$4.49M Buy
148,545
+5,165
+4% +$146K ﹤0.01% 3017
2015
Q4
$4.97M Buy
143,380
+30,601
+27% +$1.05M ﹤0.01% 2985
2015
Q3
$4.26M Buy
112,779
+1,875
+2% +$87.2K ﹤0.01% 3042
2015
Q2
$6.32M Buy
110,904
+5,511
+5% +$314K ﹤0.01% 2894
2015
Q1
$6.13M Buy
105,393
+3,198
+3% +$172K ﹤0.01% 2894
2014
Q4
$5.79M Buy
102,195
+2,452
+2% +$117K ﹤0.01% 2816
2014
Q3
$4.08M Buy
99,743
+8,635
+9% +$397K ﹤0.01% 2938
2014
Q2
$4.14M Sell
91,108
-1,874
-2% -$78.7K ﹤0.01% 2936
2014
Q1
$4.41M Buy
92,982
+3,897
+4% +$177K ﹤0.01% 2891
2013
Q4
$4.19M Sell
89,085
-23,982
-21% -$1.05M ﹤0.01% 2884
2013
Q3
$4.51M Buy
113,067
+1,979
+2% +$77.8K ﹤0.01% 2798
2013
Q2
$3.98M Buy
+111,088
New +$4.25M ﹤0.01% 2784

Other funds holding HBIO